Skip to main content

Tekla Capital Management LLC

SEC CIK
0001300336
Latest filing
Aug 10, 2023

BSX holding history

Boston Scientific Corp in every 13F filed by Tekla Capital Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2023 holdings

Shares (Q2 2023)
657,790
Value
$35.6M
% of portfolio
1.4%
Quarters held
10
Since Q1 2021
Holdings of BSX by Tekla Capital Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2023657,790$35.6M1.4%+91,800+16.2%AddedHolders
Q1 2023565,990$28.3M1.1%−191,025−25.2%ReducedHolders
Q4 2022757,015$35.0M1.3%−38,200−4.8%ReducedHolders
Q3 2022795,215$30.8M1.3%00.0%UnchangedHolders
Q2 2022795,215$29.6M1.2%+225,817+39.7%AddedHolders
Q1 2022569,398$25.2M0.9%+33,356+6.2%AddedHolders
Q4 2021536,042$22.8M0.7%+350,111+188.3%AddedHolders
Q3 2021185,931$8.07M0.3%00.0%UnchangedHolders
Q2 2021185,931$7.95M0.3%00.0%UnchangedHolders
Q1 2021185,931$7.19M0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.